[Antimicrobial susceptibility and antigen genotypes of Bordetella pertussis strains isolated from neonates]
1National Center for Children's Health/Beijing Children's Hospital, Capital Medical University/Beijing Pediatric Research Institute/National Key Discipline of Pediatrics (Capital Medical University)/National Clinical Research Center for Respiratory Diseases/Key Laboratory of Major Diseases in Children, Ministry of Education/Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing 100045, China. jiuhu2655@sina.com.
Objective:
To investigate the alternative antimicrobial drugs for the treatment of neonatal pertussis and the antigen genotypes of Bordetella pertussis (B. pertussis) strains.
Methods:
A total of 32 B. pertussis strains isolated from neonates between May 2013 and July 2018 were used in this study. E-test stripes were used to measure the minimal inhibitory concentration (MIC) of 18 antimicrobial drugs including erythromycin, sulfamethoxazole-trimethoprim (SMZ) and ampicillin. The 23S rRNA gene of isolated strains was amplified and sequenced to identify the mutation site of erythromycin resistance gene, and the seven antigen genotypes of B. pertussis strains (ptxA, ptxC, ptxP, prn, fim2, fim3 and tcfA2) were analyzed.
Results:
Of the 32 B. pertussis strains, 25 (78%) were resistant to erythromycin, azithromycin, clarithromycin and clindamycin, with an MIC of >256 mg/L, and A2047G mutation was observed in the 23S rRNA gene. All strains had an MIC of ≤0.064 mg/L for SMZ. The MIC of ampicillin, amoxicillin, amoxicillin-clavulanic acid and ceftriaxone ranged from 0.032 to 1 mg/L. The strains resistant to macrolide antibiotics had an antigen genotype of ptxA1/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2.
Conclusions:
B. pertussis strains from neonates are often resistant to macrolides, and the in vitro test shows that off-label use of sulfonamides is a reliable regimen for the treatment of neonates with macrolide-resistant pertussis. The prevalence of drug-resistant strains further emphasizes the importance of immunoprophylaxis.
Insights
Neonatal pertussis strains show high resistance to macrolides. Sulfamethoxazole-trimethoprim (SMZ) offers a reliable alternative treatment for these drug-resistant Bordetella pertussis infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Neonatal pertussis poses a significant health risk.
- Increasing antimicrobial resistance in Bordetella pertussis complicates treatment.
- Understanding resistance mechanisms and identifying alternative drugs is crucial.
Purpose of the Study:
- To evaluate alternative antimicrobial drugs for treating neonatal pertussis.
- To determine the antigen genotypes of Bordetella pertussis strains causing neonatal infections.
Main Methods:
- Minimal inhibitory concentrations (MICs) of 18 antimicrobials were tested against 32 Bordetella pertussis strains.
- 23S rRNA gene sequencing identified mutations associated with erythromycin resistance.
- Seven key antigen genotypes (ptxA, ptxC, ptxP, prn, fim2, fim3, tcfA2) were analyzed.
Main Results:
- 78% of strains were resistant to macrolides (erythromycin, azithromycin, etc.) with A2047G mutation in 23S rRNA gene.
- All strains remained susceptible to sulfamethoxazole-trimethoprim (SMZ) with low MICs.
- Macrolide-resistant strains exhibited a specific antigen genotype profile (ptxA1/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2).
Conclusions:
- Neonatal Bordetella pertussis frequently exhibits macrolide resistance.
- Sulfonamides (SMZ) show promise as an effective off-label treatment for macrolide-resistant pertussis in neonates.
- The rise of drug-resistant strains highlights the critical need for robust immunoprophylaxis strategies.
Related Concept Videos
Antimicrobial Effectiveness
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Susceptibility, Permittivity and Dielectric Constant
Thermal Strain
Shearing Strain


